Quintiles

Continuing its commitment to advancing personalized medicine by offering world-leading experts and cutting-edge tools, Quintiles today announced that it has invested in a new company formed to provide ... read more

With the ringing in of the new year, patients and family members of the now bygone Google Health can still find a well established, thriving and successful online ... read more

Quintiles today announced the formation of its new Digital Patient unit, which, for the first time, brings together the company’s online communities and digital expertise to directly engage ... read more

To speed development of a potential ground-breaking therapy for Type 2 diabetes – a debilitating and deadly disease that currently affects almost 350 million people worldwide – Intarcia ... read more

Further deepening its commitment to China, Quintiles today announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the ... read more

Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles today announced the opening of a new, expanded central lab in ... read more

Quintiles today announced an expanded partnership with Jakarta-based Prodia Clinical Laboratory, through its sister company Prodia the CRO, to facilitate rapid testing ... read more

For the fourth time in six years, Quintiles has been named Asia Pacific Contract Research Organization of the Year by Frost & Sullivan, a leading business research and ... read more

Quintiles announced today that it has sold its minority interest in Invida, an Asia Pacific commercial solutions joint venture, to the Italy-based ... read more

Quintiles’ ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with ... read more

Quintiles’ digital efforts to bridge the gaps between clinical research, patients and clinical trial participants have been recognized in the form of two International ... read more

Quintiles is ranked 25th in the inaugural World’s Best Multinational Workplaces list from the Great Place to Work® Institute. The rankings were announced during a reception at the ... read more

To provide a more comprehensive and efficient global solution for its laboratory customers, Quintiles today announced the signing of a definitive agreement to acquire Advion ... read more

With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles today announced it has acquired Outcome Sciences, Inc. (Outcome), a ... read more

Quintiles today announced the acquisition of VCG & Associates and VCG BIO, based in Holliston, Mass., and Cave Creek, Ariz., respectively. ... read more

Quintiles today announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit, the core of the company’s ... read more

Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development, according to a new report from Quintiles, titled An ... read more

While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with ... read more

Quintiles has named Charles Williams to serve as its worldwide controller within the company’s finance organization. Charles Williams, Quintiles Worldwide ... read more

A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a ... read more